Viewing Study NCT00335088



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00335088
Status: UNKNOWN
Last Update Posted: 2007-06-01
First Post: 2006-06-05

Brief Title: Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations
Sponsor: HaEmek Medical Center Israel
Organization: HaEmek Medical Center Israel

Study Overview

Official Title: None
Status: UNKNOWN
Status Verified Date: 2007-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The hypothesis is that povidone iodine alone is sufficient for sterilization of the lacrimal sac and eye lids before intraocular surgeries Patients admitted for various intraocular surgeries will be randomly allocated to prophylactic local therapy with either moxifloxacin and povidone iodine or povidone iodine alone before surgery Lacrimal sac and eye lid cultures will be obtained before the local therapy and just before surgery
Detailed Description: Over all 500 patients admitted for various intraocular surgeries will be included in the study The study will be prospective double blind placebo controlled and randomized Patients will be randomly allocated to prophylactic local therapy with either moxifloxacin and povidone iodine or povidone iodine alone before surgery For patients treated with povidone iodine alone a placebo will also be given Lacrimal sac and eye lid cultures will be obtained before the local therapy and just before surgery All patients will be followed for 6 weeks for symptoms and signs of infection Bacterial and fungal culture results will be compared between the 2 groups

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None